Our study found that rectal insulin instillation exacerbated colitis through the regulatory effect of EZH2 on TRM, suggesting that both insulin inhibitor and EZH2 inhibitor could be potential drugs for IBD treatment. The gene discussed is EZH2; the disease is inflammatory bowel disease.